会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Pulsatile fluid delivery system
    • 脉动流体输送系统
    • US07842003B2
    • 2010-11-30
    • US11297989
    • 2005-12-09
    • Kenneth A. JonesCristo Suresh CoreraRichard S. Hayes
    • Kenneth A. JonesCristo Suresh CoreraRichard S. Hayes
    • A61M37/00F04B43/12A61N1/362
    • F04B49/065
    • A system for delivering blood, cardioplegia solution, and other medications or fluids in a pulsatile flow pattern to a patient during cardiopulmonary bypass is disclosed. In a preferred embodiment, a pumping apparatus having at least one chamber is utilized in which a pumping action is achieved by compressing one of the chambers with a piston mechanism, while allowing the other chamber to fill with fluid via retracting its respective piston. The instantaneous flow rate of either of the chambers is determined by the speed of the piston. In a preferred embodiment, a pulsatile flow of fluid is achieved by cyclically alternating the velocity of the piston between two different speeds. A desired average flow rate and/or delivery pressure and/or constant pulse pressure is maintained by adjusting the alternating velocities at the desired frequency and duty cycle. The calculations necessary to obtain a desired average flow rate are performed by a microprocessor, which also controls the movement of the pistons.
    • 公开了一种用于在体外循环期间向患者输送血液,心麻痹液和脉动流动模式的其它药物或流体的系统。 在优选实施例中,使用具有至少一个室的泵送装置,其中通过用活塞机构压缩其中一个室来实现泵送作用,同时允许另一个室通过缩回其相应的活塞来填充流体。 任何一个室的瞬时流量由活塞的速度决定。 在优选实施例中,通过在两个不同速度之间循环地交替活塞的速度来实现流体的脉动流。 通过在所需的频率和占空比下调节交变速度来维持期望的平均流速和/或输送压力和/或恒定脉冲压力。 获得所需平均流量所需的计算由微处理器执行,微处理器也控制活塞的运动。
    • 3. 发明授权
    • Processes for determining compounds that interact with snorf33 receptor
    • 确定与snorf33受体相互作用的化合物的方法
    • US07371535B2
    • 2008-05-13
    • US11217710
    • 2005-09-01
    • Beth E. BorowskyKristine L. OgozalekKenneth A. Jones
    • Beth E. BorowskyKristine L. OgozalekKenneth A. Jones
    • G01N33/566G01N33/53
    • C07K14/705A61K38/00A61K48/00
    • This invention provides isolated nucleic acids encoding mammalian SNORF33 receptors, purified mammalian SNORF33 receptors, vectors comprising nucleic acid encoding mammalian SNORF33 receptors, cells comprising such vectors, antibodies directed to mammalian SNORF33 receptors, nucleic acid probes useful for detecting nucleic acid encoding mammalian SNORF33 receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding mammalian SNORF33 receptors, transgenic, nonhuman animals which express DNA encoding normal or mutant mammalian SNORF33 receptors, methods of isolating mammalian SNORF33 receptors, methods of treating an abnormality that is linked to the activity of the mammalian SNORF33 receptors, as well as methods of determining binding of compounds to mammalian SNORF33 receptors, methods of identifying agonists and antagonists of SNORF33 receptors, and agonists and antagonists so identified.
    • 本发明提供编码哺乳动物SNORF33受体的分离的核酸,纯化的哺乳动物SNORF33受体,包含编码哺乳动物SNORF33受体的核酸的载体,包含此类载体的细胞,针对哺乳动物SNORF33受体的抗体,用于检测编码哺乳动物SNORF33受体的核酸的核酸探针, 与编码哺乳动物SNORF33受体的核酸的独特序列互补的反义寡核苷酸,表达编码正常或突变的哺乳动物SNORF33受体的DNA的转基因非人动物,分离哺乳动物SNORF33受体的方法,治疗与哺乳动物的活性相关的异常的方法 SNORF33受体以及确定化合物与哺乳动物SNORF33受体的结合的方法,识别SNORF33受体的激动剂和拮抗剂的方法,以及所鉴定的激动剂和拮抗剂。
    • 4. 发明授权
    • DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
    • 编码哺乳动物神经肽FF(NPFF)受体的DNA及其用途
    • US07276339B2
    • 2007-10-02
    • US10992577
    • 2004-11-18
    • Christophe P. G. GeraldKenneth A. JonesJames A. BoniniBeth E. BorowskyDouglas A. Craig
    • Christophe P. G. GeraldKenneth A. JonesJames A. BoniniBeth E. BorowskyDouglas A. Craig
    • C12Q1/68G01N33/53C12N15/00
    • C07K14/70571A01K2217/075
    • This invention provides isolated nucleic acids encoding mammalian NPFF receptors, purified mammalian NPFF receptors, vectors comprising nucleic acid encoding mammalian NPFF receptors, cells comprising such vectors, antibodies directed to mammalian NPFF receptors, nucleic acid probes useful for detecting nucleic acid encoding mammalian NPFF receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding mammalian NPFF receptors, transgenic, nonhuman animals which express DNA encoding normal or mutant mammalian NPFF receptors, methods of isolating mammalian NPFF receptors, methods of treating an abnormality that is linked to the activity of the mammalian NPFF receptors, as well as methods of determining binding of compounds to mammalian NPFF receptors, methods of identifying agonists and antagonists of NPFF receptors, and agonists and antagonists so identified.
    • 本发明提供编码哺乳动物NPFF受体的分离的核酸,纯化的哺乳动物NPFF受体,包含编码哺乳动物NPFF受体的核酸的载体,包含该载体的细胞,针对哺乳动物NPFF受体的抗体,用于检测编码哺乳动物NPFF受体的核酸的核酸探针, 与编码哺乳动物NPFF受体的核酸的独特序列互补的反义寡核苷酸,其表达编码正常或突变型哺乳动物NPFF受体的DNA的转基因非人动物,分离哺乳动物NPFF受体的方法,治疗与哺乳动物活性相关的异常的方法 NPFF受体,以及确定化合物与哺乳动物NPFF受体的结合的方法,识别NPFF受体的激动剂和拮抗剂的方法,以及如此鉴定的激动剂和拮抗剂。
    • 5. 发明授权
    • Chimeric G proteins and uses thereof
    • 嵌合G蛋白及其用途
    • US07067277B1
    • 2006-06-27
    • US09471572
    • 1999-12-23
    • Kenneth A. JonesMary W. WalkerJoseph TammTheresa A. BranchekChristophe P. G. Gerald
    • Kenneth A. JonesMary W. WalkerJoseph TammTheresa A. BranchekChristophe P. G. Gerald
    • C12N15/12C12N15/63C12N15/00C07H21/04C07K14/00
    • C07K14/43581C07K14/43545
    • This invention provides isolated nucleic acids encoding chimeric G proteins, vectors comprising nucleic acids encoding chimeric G proteins, cells comprising such vectors, processes of determining agonists and antagonists of mammalian G protein-coupled receptors utilizing chimeric G proteins, processes of determining compounds which bind to mammalian G protein-coupled receptors utilizing chimeric G proteins, processes for making a composition of matter which specifically binds to a mammalian G protein-coupled receptor utilizing chimeric G proteins, processes for preparing a composition which comprises admixing a carrier and a pharmaceutically effective amount of a chemical compound identified by a process of the invention utilizing chimeric G proteins, processes of identifying a ligand for a mammalian G protein-coupled receptor utilizing chimeric G proteins, and processes of screening a plurality of independent clones to identify and isolate a clone encoding a mammalian G protein-coupled receptor utilizing chimeric G proteins.
    • 本发明提供编码嵌合G蛋白的分离的核酸,包含编码嵌合G蛋白的核酸的载体,包含此类载体的细胞,利用嵌合G蛋白确定哺乳动物G蛋白偶联受体的激动剂和拮抗剂的方法,确定与 使用嵌合G蛋白的哺乳动物G蛋白偶联受体,使用嵌合G蛋白特异性结合哺乳动物G蛋白偶联受体的物质组合物的方法,制备组合物的方法,该组合物包含将载体和药学上有效量的 通过利用嵌合G蛋白的本发明方法鉴定的化合物,利用嵌合G蛋白鉴定哺乳动物G蛋白偶联受体的配体的方法,以及筛选多个独立克隆以识别和分离编码 哺乳动物G蛋白偶联 d受体。